https://pubmed.ncbi.nlm.nih.gov/14512185/?dopt=Abstract
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839...
ZD1839 ('Iressa') is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that inhibits EGFR signaling. Emerging evidence indicates that...
lung cancer cell lines
https://erbb1.com/index.php?g=Wap&m=Article&a=detail&id=15557
Gefitinib (ZD1839): Next-Generation EGFR Inhibition in Co...
next generationgefitinibegfrinhibitionco